Ha Tay Pharmaceutical JSC

HNX-DHT
Hanoi Stock Exchange NYSE
Pharmaceutical Preparations
Global Rank
#18338
Country Rank
n/a
Market Cap
258.45 M
Price
3.14
Change (%)
0.36%
Volume
5,702

HNX-DHT's Next Dividend

Next Estimated Amount
₫550
Next Estimated Pay Date
09/28/2025
Last Amount
₫500
Last Pay Date
11/29/2024
Dividend Shot Clock Ex-Date: 10/30/2024
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

Ha Tay Pharmaceutical JSC Dividend Chart

*Amounts are shown in the stock exchange currency (VND) for convenience

Ha Tay Pharmaceutical JSC(HNX-DHT) Dividend History

Ha Tay Pharmaceutical JSC (HNX-DHT) currently pays an annual dividend of $500.00 per share, offering a dividend yield of 1.21%. The next dividend payout date has not been announced.
Ex-Dividend Date Adj. Amount Record Date Pay Date Change (%)
2024 ₫1,000 40%
10/30/2024 ₫500 10/31/2024 11/29/2024 0%
01/19/2024 ₫500 01/22/2024 01/31/2024 40%
2022 ₫714.28 100%
11/21/2022 ₫357.14 11/22/2022 11/29/2022 0%
01/11/2022 ₫357.14 01/12/2022 01/20/2022 0%
2020 ₫357.14
12/03/2020 ₫357.14 12/04/2020 01/29/2021
*Amounts are shown in the stock exchange currency (VND) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.